EPILIM CHRONO

This brand name is authorized in Nigeria. It is also authorized in Hong Kong SAR China, Ireland, Malta, Singapore, UK.

Active ingredients

The drug EPILIM CHRONO contains a combination of these active pharmaceutical ingredients (APIs):

1	Sodium valproate UNII 5VOM6GYJ0D - VALPROATE SODIUM
	Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA.
	Read more about Valproic acid
2	Valproic acid UNII 614OI1Z5WI - VALPROIC ACID
	Valproic acid is anti-convulsant. The most likely mode of action for valproate is potentiation of the inhibitory action of gamma amino butyric acid (GABA) through an action on the further synthesis or further metabolism of GABA.
	Read more about Valproic acid

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-2456	Tablet	Epilim Chrono 500mg Tablets TAB 333 mg; 145 mg	EPILIM CHRONO 500MG TABLETS 04-2456 EPILIM CHRONO 500MG TABLETS Sodium Valproate 333mg and Valproic Acid 145mg,Hypermellose (E464), Ethylcellulose, Hydrated silica, Titanum dioxide(E171), Erythrosine BS Aluminium lake (E127), Indigo Carmine aluminium lake FD and C Blue No 2 (E1320, Iron dxide black (E1720, Macrogol 400 Prescription Only Medicine (POM) SANOFI-AVENTIS NIGERIA LIMITED, JAPAUL HOUSE, DR.NURUDEEN OLOWOPOPO AVENUE IKEJA LAGOS SANOFI WINTHROP INDUSTRIE, AMBARES - FRANCE, 1, RUE DE LA VIERGE, AMBARES ET LAGRAVE, 33565 CARBON BLANC CEDEX - FRANCE, France 23/02/2023 22/02/2028	23/02/2023

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EPILIM CHRONOSPHERE Modified release granules	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AG01	Valproic acid	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AG Fatty acid derivatives
Discover more medicines within N03AG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	136655, 136658, 136661, 136664, 136667, 142210, 142212, 142214, 154395, 161721, 161723, 161725, 364480, 364482, 364484, 373568, 373570, 373625, 373627, 373629, 373811, 378890, 379498, 379499, 391370, 391372, 398340, 398351
HK	Department of Health Drug Office	39203, 39204, 39205
IE	Health Products Regulatory Authority	37038, 37039, 37040
MT	Medicines Authority	MA1359/01901, MA1359/01902
NG	Registered Drug Product Database	04-2456
SG	Health Sciences Authority	08112P, 08484P, 08537P